Loading…
avatar for Tony Catka

Tony Catka

Addison Whitney, A Syneos Health Company
Senior Director, Regulatory Affairs
As the Lead of Addison Whitney's Center for Regulatory Guidance, Tony ensures that Addison Whitney stays abreast of changes that affect drug naming worldwide. He provides analysis of regulatory guidance, precedents, and the emerging environment and collaborates with team members in the correct use and application of naming rules and regulatory tools such as POCA in the evaluation of potential non-proprietary and proprietary names. Tony has over 30 years of regulatory affairs experience in life science industries including DuPont, AstraZeneca, Accenture and Syneos Health. He holds a B.S. in Chemistry from the University of Detroit, and a Ph.D from the University of Minnesota.